» Articles » PMID: 35576497

Serum Transfer RNA-derived Fragment TRF-31-79MP9P9NH57SD Acts As a Novel Diagnostic Biomarker for Non-small Cell Lung Cancer

Overview
Journal J Clin Lab Anal
Publisher Wiley
Date 2022 May 16
PMID 35576497
Authors
Affiliations
Soon will be listed here.
Abstract

Background: tRNA-derived fragments (tRFs) have been found to have a crucial function in the pathophysiology of cancers. However, the function of tRFs in non-small cell lung cancer (NSCLC) is yet unknown. The goal of this study was to assess the tRF-31-79MP9P9NH57SD serum expression from NSCLC patients and to determine its diagnostic usefulness.

Methods: By using stem-loop quantitative real-time PCR, we were able to detect various tRF-31-79MP9P9NH57SD expressions in 96 NSCLC serum samples, 96 healthy controls, and 20 pairs of NSCLC serum samples pre- and post-surgery (qRT-PCR). After that, we analyzed its diagnostic effectiveness using the receiver operating characteristic (ROC) curve.

Results: Serum tRF-31-79MP9P9NH57SD expression was higher in NSCLC patients, and levels of tRF-31-79MP9P9NH57SD were linked to the clinical stage (p = 0.002) and the malignancy of lymph node (p = 0.012). In addition, after the procedure, the serum tRF-31-79MP9P9NH57SD expression in NSCLC patients dropped. With 48.96 percent sensitivity and 90.62 percent specificity, the area under ROC curve (AUC) was 0.733.

Conclusion: serum tRF-31-79MP9P9NH57SD possibly is a new and groundbreaking biomarker for the NSCLC.

Citing Articles

Diagnostic and prognostic values of tsRNAs in lung cancer: a meta-analysis.

Tang C, Sun S, Gu C, Li C, Xu J, Su K BMC Cancer. 2025; 25(1):153.

PMID: 39871144 PMC: 11770914. DOI: 10.1186/s12885-025-13536-y.


Research progress on the tsRNA biogenesis, function, and application in lung cancer.

Chen Y, Shao Z, Wu S Noncoding RNA Res. 2024; 10:63-69.

PMID: 39309197 PMC: 11414277. DOI: 10.1016/j.ncrna.2024.09.004.


Epigallocatechin gallate modulates ferroptosis through downregulation of tsRNA-13502 in non-small cell lung cancer.

Wang S, Wang R, Hu D, Zhang C, Cao P, Huang J Cancer Cell Int. 2024; 24(1):200.

PMID: 38840243 PMC: 11155022. DOI: 10.1186/s12935-024-03391-5.


Emerging roles of tRNA-derived fragments in cancer.

Fu M, Gu J, Wang M, Zhang J, Chen Y, Jiang P Mol Cancer. 2023; 22(1):30.

PMID: 36782290 PMC: 9926655. DOI: 10.1186/s12943-023-01739-5.


Establishment of an Absolute Quantitative Method to Detect a Plasma tRNA-Derived Fragment and Its Application in the Non-Invasive Diagnosis of Gastric Cancer.

Yu X, Song X, Xie Y, Zhang S, Guo J Int J Mol Sci. 2023; 24(1).

PMID: 36613767 PMC: 9820402. DOI: 10.3390/ijms24010322.


References
1.
Goodarzi H, Liu X, Nguyen H, Zhang S, Fish L, Tavazoie S . Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement. Cell. 2015; 161(4):790-802. PMC: 4457382. DOI: 10.1016/j.cell.2015.02.053. View

2.
Zhou Y, Cui Q, Zhou Y . Screening and Comprehensive Analysis of Cancer-Associated tRNA-Derived Fragments. Front Genet. 2022; 12:747931. PMC: 8795687. DOI: 10.3389/fgene.2021.747931. View

3.
Camidge D, Doebele R, Kerr K . Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC. Nat Rev Clin Oncol. 2019; 16(6):341-355. DOI: 10.1038/s41571-019-0173-9. View

4.
Mo D, He F, Zheng J, Chen H, Tang L, Yan F . tRNA-Derived Fragment tRF-17-79MP9PP Attenuates Cell Invasion and Migration THBS1/TGF-β1/Smad3 Axis in Breast Cancer. Front Oncol. 2021; 11:656078. PMC: 8072113. DOI: 10.3389/fonc.2021.656078. View

5.
Zhu P, Yu J, Zhou P . Role of tRNA-derived fragments in cancer: novel diagnostic and therapeutic targets tRFs in cancer. Am J Cancer Res. 2020; 10(2):393-402. PMC: 7061753. View